Legend Biotech Corp. (LEGN)
17.79
-0.83
(-4.46%)
USD |
NASDAQ |
Oct 12, 16:00
17.80
+0.01
(+0.06%)
After-Hours: 20:00
Legend Biotech Cash and Short Term Investments (Quarterly) : 964.63M for June 30, 2026
Cash and Short Term Investments (Quarterly) Chart
Historical Cash and Short Term Investments (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 964.63M |
| March 31, 2026 | 834.63M |
| December 31, 2025 | 948.60M |
| September 30, 2025 | 992.66M |
| June 30, 2025 | 967.64M |
| March 31, 2025 | 1.005B |
| December 31, 2024 | 1.123B |
| September 30, 2024 | 1.213B |
| June 30, 2024 | 1.292B |
| March 31, 2024 | 1.303B |
| December 31, 2023 | 1.309B |
| September 30, 2023 | 1.424B |
| June 30, 2023 | 1.516B |
| March 31, 2023 | 851.40M |
| Date | Value |
|---|---|
| December 31, 2022 | 1.027B |
| September 30, 2022 | |
| June 30, 2022 | 784.51M |
| March 31, 2022 | 792.71M |
| December 31, 2021 | 883.84M |
| September 30, 2021 | 606.54M |
| June 30, 2021 | 692.96M |
| March 31, 2021 | 462.57M |
| December 31, 2020 | 506.07M |
| September 30, 2020 | 576.54M |
| June 30, 2020 | 638.21M |
| March 31, 2020 | 246.73M |
| December 31, 2019 | 159.18M |
Cash and Short Term Investments Definition
Represents the sum of cash and short term investments.
Cash and Short Term Investments (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Cash and Short Term Investments (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 4.882B |
| Ionis Pharmaceuticals, Inc. | 2.055B |
| Johnson & Johnson | 20.76B |
| Arbutus Biopharma Corp. | 92.62M |
| Capricor Therapeutics, Inc. | 237.93M |